ACEP senior leadership recently attended the American College of Surgeons Committee on Trauma (ACS COT) meeting. The group discussed achieving greater involvement in the Trauma Center Verification Program. Also discussed was a revision of the REBOA statement.
ACEP participated in a small meeting of several medical specialty associations with America’s Health Insurance Plans (AHIP) and several private payers to discuss how to expand access to non-opioid treatments and other pain management strategies to address chronic low back pain.
ACEP was invited to participate in a meeting at the Food and Drug Administration (FDA) on drug compounding. The FDA was seeking input from physician groups, and ACEP member Craig Manifold, DO, FACEP, and ACEP staff Jeff Davis attended to provide the emergency medicine prospective.